Company Overview of ExSAR Corporation
ExSAR Corporation, a biopharmaceutical company, identifies, develops, and commercializes small-molecule therapeutics for protein misfolding diseases. Its products include EXR-101 for the treatment of Late-Onset Tay-Sachs; and EXR-202 for the treatment of Gaucher disease. The company provides drug discovery services to pharmaceutical, biotechnology, and academic laboratories. ExSAR Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.
11 Deer Park Drive
Monmouth Junction, NJ 08852
Founded in 1997
Key Executives for ExSAR Corporation
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ExSAR Corporation, please visit www.exsar.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.